Literature DB >> 8477763

The value of new antimicrobial agents.

J H Wagenvoort1.   

Abstract

New antimicrobial agents require careful assessment to determine whether they possess the appropriate properties for clinical use. Many new compounds of value in the prophylaxis and therapy of infections have been included in the current armamentarium. Close monitoring to identify possible adverse effects of new agents is essential. Alternative uses of older agents also expands therapeutic opportunities in the combat against infectious diseases. Inappropriate use of antimicrobial agents contributes to the worldwide problem of increasing bacterial resistance. The dramatic spread of such bacterial strains is partially responsible for the rising costs of infectious diseases. A rational and strict antibiotic policy is thus of great importance for the optimal use of these agents.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8477763     DOI: 10.1007/bf02389878

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  Resistance to beta-lactam antibiotics and ciprofloxacin in gram-negative bacilli and staphylococci isolated from blood: a European collaborative study. European Study Group on Antibiotic Resistance.

Authors:  K Dornbusch
Journal:  J Antimicrob Chemother       Date:  1990-08       Impact factor: 5.790

2.  Responsibility of the infectious disease community for optimal use of antibiotics: views of the membership of the Infectious Diseases Society of America.

Authors:  C M Kunin; S Chambers
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug

Review 3.  Treatment of Chlamydia trachomatis genital infection.

Authors:  K E Toomey; R C Barnes
Journal:  Rev Infect Dis       Date:  1990 Jul-Aug

4.  The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients.

Authors:  J R Boelaert; R A De Smedt; Y A De Baere; C A Godard; E G Matthys; M L Schurgers; R F Daneels; B Z Gordts; H W Van Landuyt
Journal:  Nephrol Dial Transplant       Date:  1989       Impact factor: 5.992

Review 5.  Once-daily aminoglycoside administration: new strategies for an old drug.

Authors:  J M Kovarik; I M Hoepelman; J Verhoef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

6.  Randomized comparative study of 0.5 and 1 g of cefodizime (HR 221) versus 1 g of cefotaxime for acute uncomplicated urogenital gonorrhea.

Authors:  A H van der Willigen; J H Wagenvoort; W O Schalla; J S Knapp; J M Boot; P L Heeres-Weststrate; M F Michel; B van Klingeren; E Stolz
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

Review 7.  Problems in evaluation of adverse reactions to beta-lactam antibiotics.

Authors:  S R Norrby
Journal:  Rev Infect Dis       Date:  1986 Jul-Aug

8.  Incidence of multi-resistant gram-negative isolates in eight Dutch hospitals. The 1990 Dutch Surveillance Study.

Authors:  R J Buirma; A M Horrevorts; J H Wagenvoort
Journal:  Scand J Infect Dis Suppl       Date:  1991

9.  The development of macrolides: clarithromycin in perspective.

Authors:  H C Neu
Journal:  J Antimicrob Chemother       Date:  1991-02       Impact factor: 5.790

10.  Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit.

Authors:  C Brun-Buisson; P Legrand; A Rauss; C Richard; F Montravers; M Besbes; J L Meakins; C J Soussy; F Lemaire
Journal:  Ann Intern Med       Date:  1989-06-01       Impact factor: 25.391

View more
  2 in total

1.  Antimicrobial utilization and bacterial resistance at three different hospitals.

Authors:  V Vlahović-Palcevski; M Morović; G Palcevski; L Betica-Radić
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Randomized, double-blind comparison of single-dose regimens of rufloxacin and pefloxacin for acute uncomplicated cystitis in women. French Multicenter Urinary Tract Infection-Rufloxacin Group.

Authors:  A Jardin; M Cesana
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.